StockData
Viemed Healthcare, Inc. logo

Viemed Healthcare, Inc. (VMD) company profile

VMDNasdaqServices-Misc Health & Allied Services, NECFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 4, 2026Score 18/3020% below fair value
$9.17+0.06 (+0.66%)

Close on Nov 13, 2026Market cap $349.27MP/E 24.1Yield –

About Viemed Healthcare

Services-Misc Health & Allied Services, NEC, SIC 8090

Viemed Healthcare, Inc. supplies home medical equipment and post-acute clinical care services, primarily focusing on respiratory therapy, chronic disease management, and women's health. The company provides medical devices largely through rental arrangements, including invasive and non-invasive home ventilators, continuous positive airway pressure units, oxygen therapy equipment, and percussion vests. Additional offerings include home sleep apnea testing, lactation supplies such as breast pumps, and clinical recruitment services. Its client base consists of patients managing chronic illnesses like chronic obstructive pulmonary disease and neuromuscular disorders at home, along with healthcare institutions seeking supplemental clinical personnel.

The company operates across all 50 states within the United States. As of late 2025, its staff includes 401 licensed respiratory therapists, comprising nearly thirty percent of its total workforce. Viemed Healthcare maintains its principal executive offices in Lafayette, Louisiana, with registered corporate records offices situated in Vancouver, British Columbia.

Summary of the business section of Viemed Healthcare's latest annual report, written by StockData.

Company profile

Company

Legal name
Viemed Healthcare, Inc.
Founded
2016
Headquarters
Lafayette, LA
Address
625 E. Kaliste Saloom Rd. 70508
Phone
(337) 504-3802
Website
viemed.com
Employees
1,382, Dec 31, 2025
Industry
Services-Misc Health & Allied Services, NEC
Incorporated in
A1
Fiscal year ends
December 31
Auditor
Ernst & Young LLP, New Orleans, Louisiana

Stock & identifiers

Ticker
VMD
Exchange
Nasdaq
IPO date
Aug 9, 2019
Shares outstanding
38M, Jul 27, 2026
Public float
$238.79M, Jun 30, 2025
Filer category
Accelerated filer
SEC CIK
1729149
CUSIP
92663R105
ISIN
CA92663R1055
FIGI
BBG00JNKPJ36
Share class FIGI
BBG00JB5VKK3
EIN
00-0000000

Executives and directors

Officers and directors who filed ownership reports (Forms 3, 4, 5) in the last two years

NamePositionShares owned
William FrazierChief Medical Officer, Director83,214
Casey HoytChief Executive Officer, Director2,349,320
William Todd ZehnderChief Operating Officer, Director401,677
Michael MoorePresident1,774,902
Jeremy TrahanGeneral Counsel49,431
Jerome CambreVice President of Sales106,443
Trae FitzgeraldChief Financial Officer105,638
Nitin KaushalDirector161,361
Sabrina HeltzDirector82,520
Randy E. DobbsDirector142,253
Timothy SmokoffDirector94,304

CEO pay and shareholder return

Pay versus performance table from the proxy statement

Fiscal yearCEO total payCEO pay actually paidOther executives (avg)Value of $100 investedPeer group
FY2025$2.63M$2.27M$1.99M$142$100
FY2024$2.62M$2.51M$1.46M$154$85
FY2023$2.51M$2.49M$1.38M$150$84
FY2022$1.93M$2.76M$1.06M$145$80

“Actually paid” adjusts reported pay for changes in the value of equity awards. Shareholder return assumes $100 invested at the start of the measurement period, as disclosed by the company.

Executive compensation, fiscal 2025

Summary compensation table from the latest proxy statement

ExecutiveSalaryBonusStock awardsIncentive payOtherTotalvs. prior year
Casey Hoyt
Chief Executive Officer and Director
$549.38K$2.76K$1.52M$511.30K$47.02K$2.63M+0%
Michael Moore
President
$463.21K$2.76K$1.05M$431.10K$76.43K$2.02M+0%
W. Todd Zehnder
Chief Operating Officer and Director
$463.21K$7.76K$3.08M$431.10K$65.85K$4.05M+103%
Trae Fitzgerald
Chief Financial Officer
$271.24K$2.76K$406.98K$190.56K$43.29K$914.83K+5%
Jeremy Trahan
General Counsel
$296.57K$2.76K$447.68K$205.66K$34.43K$987.09K+4%

Stock and option awards are grant-date fair values, not realized pay. “Other” includes pension value changes and all other compensation. Source proxy statement.

Employees

Headcount reported in annual reports

“At December 31, 2025, Viemed had 1,382 permanent employees, in addition to temporary employees and independent contractors engaged through the Company's healthcare staffing and recruitment services to supplement the workforce needs of third-party healthcare facilities.”

Corporate history

Events identified from SEC filings

See a number that looks wrong?